Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets

By Sudo Toshiki   Ito Hideki   Kimura Yukio  

Platelets, Vol. 14, Iss. 6, 2003-09 ,pp. : 381-390

Informa Healthcare

Access to resources Recommend Favorite

Anti-platelet antibodies in a natural animal model of sulphonamide-associated thrombocytopaenia

By Lavergne Sidonie   Trepanier Lauren  

Platelets, Vol. 18, Iss. 8, 2007-12 ,pp. : 595-604

Informa Healthcare

Access to resources Recommend Favorite

Human Anti-heparin-Platelet Factor 4 Antibodies Are Capable of Activating Primate Platelets - Towards the Development of a HIT Model in Primates

By Ahmad S.   Jeske W.P.   Walenga J.M.   Aldabbagh A.   Iqbal O.   Fareed J.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 47-54

Elsevier

Access to resources Recommend Favorite

Effects of Recombinant Human Megakaryocyte Growth and Development Factor (rHuMGDF) on Platelet Production, Platelet Aggregation, and Thrombosis

By Lott F.D.   Nelson A.G.   Toombs C.F.  

Journal of Thrombosis and Thrombolysis, Vol. 5, Iss. 1, 1998-01 ,pp. : 15-23

Springer Publishing Company

Access to resources Recommend Favorite

A paradigm shift in anti-platelet therapy?

By Bonello L.   Barragan P.   Paganelli F.  

Platelets, Vol. 19, Iss. 8, 2008-12 ,pp. : 562-564

Informa Healthcare

Access to resources Recommend Favorite